Biotech and the New Reality of VC Fundraising | Ep. 624
Big Funds, Long Cycles, and Tougher Markets
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was DOWN -2% and remains red at -5% for the year. In today’s newsletter, we’re digging into the shifting landscape of venture capital - who’s raising, where the money is flowing, and what it means …
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.